Munar Pharma

Munar Pharma Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -0.27. In the previous year, Financial Leverage (Equity Multiplier) was -0.68 — a change of -60.94% (higher).

Financial Leverage

-0.27

YoY

-60.94%

Last updated:

Financial Leverage (Equity Multiplier) of Munar Pharma is 2024 -0.27 . Financial Leverage (Equity Multiplier) of Munar Pharma was 2023 -0.68 . It decreases by -60.94% higher compared to the previous year.

The Munar Pharma Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2017
1.03 PLN
Jan 1, 2018
1.86 PLN
Jan 1, 2019
2.41 PLN
Jan 1, 2020
2.58 PLN
Jan 1, 2021
2.02 PLN
Jan 1, 2022
2.06 PLN
Jan 1, 2023
-0.68 PLN
Jan 1, 2024
-0.27 PLN
The Munar Pharma Financial Leverage history
YEARFinancial LeverageYoY
-0.27-60.94%
-0.68-133.14%
2.06+2.21%
2.02-21.85%
2.58+7.06%
2.41+29.91%
1.86+80.09%
1.03-49.62%
2.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

Financial Leverage (Equity Multiplier) of Munar Pharma is -0.27 in 2024.

Financial Leverage (Equity Multiplier) of Munar Pharma changed from -0.68 to -0.27, representing a -60.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Munar Pharma

All Key Metrics — Munar Pharma